tm logo
Trademark Search
BLAUTIX

View On IC.GC.CA

BLAUTIX
REGISTERED

on 04 Feb 2021

Last Applicant/ Owned by

4D PHARMA PLC

9 Bond Court,Leeds, England, LS1 2JZ

GB

Serial Number

1897441 filed on 04th May 2018

Registration Number

TMA1093113 registered on 04th Feb 2021

Registration expiry Date

04th Feb 2031

Correspondent Address

333 BAY STREET, SUITE 2400BAY ADELAIDE CENTRE, BOX 20TORONTO

ONTARIO

CA

M5H2T6

BLAUTIX

Trademark usage description

pharmaceuticals and pharmaceuticals as live biotherapeutics for the treatment of brain injuries, namely strokes and ischemic events, central nervous s Read More

Classification Information

Class [005]
Pharmaceuticals and pharmaceuticals as live biotherapeutics for the treatment of brain injuries, namely strokes and ischemic events, central nervous system disorders, namely, multiple sclerosis, autism, obsessive compulsive disorder, depression, anxiety and neurodegenerative disorders, namely Parkinson's disease and Alzheimer's Disease, cancer, bowel disorders, namely, visceral hypersensitivity, diarrhea, constipation, bacterial infections, dysbiosis, irritable bowel syndrome and inflammatory bowel disorders, namely Crohn's disease and ulcerative colitis, lung disorders and diseases, namely, asthma, chronic obstructive pulmonary disease and acute respiratory distress syndrome, inflammatory diseases, namely arthritis and autoimmune diseases; Live biotherapeutics and live biotherapeutic bacterial formulations for the treatment of brain injuries, namely strokes and ischemic events, central nervous system disorders, namely, multiple sclerosis, autism, obsessive compulsive disorder, depression, anxiety and neurodegenerative disorders, namely Parkinson's disease and Alzheimer's Disease, cancer, bowel disorders, namely, visceral hypersensitivity, diarrhea, constipation, bacterial infections, dysbiosis, irritable bowel syndrome and inflammatory bowel disorders, namely Crohn's disease and ulcerative colitis, lung disorders and diseases, namely, asthma, chronic obstructive pulmonary disease and acute respiratory distress syndrome, inflammatory diseases, namely arthritis and autoimmune diseases; Preparations of microorganisms for the treatment of brain injuries, namely strokes and ischemic events, central nervous system disorders, namely, multiple sclerosis, autism, obsessive compulsive disorder, depression, anxiety and neurodegenerative disorders, namely Parkinson's disease and Alzheimer's Disease, cancer, bowel disorders, namely, visceral hypersensitivity, diarrhea, constipation, bacterial infections, dysbiosis, irritable bowel syndrome and inflammatory bowel disorders, namely Crohn's disease and ulcerative colitis, lung disorders and diseases, namely, asthma, chronic obstructive pulmonary disease and acute respiratory distress syndrome, inflammatory diseases, namely arthritis and autoimmune diseases

Classification kind code

11

Mark Details

Serial Number

1897441

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 190
on 09th Dec 2020		Registration Pending
Submitted for opposition 42
on 16th Sep 2020		Advertised
Submitted for opposition 27
on 24th Aug 2020		Approval Notice Sent
Submitted for opposition 26
on 24th Aug 2020		Approved
Submitted for opposition 15
on 17th Jun 2020		Correspondence Created
Submitted for opposition 22
on 10th Oct 2019		Search Recorded
Submitted for opposition 20
on 10th Oct 2019		Examiner's First Report
Submitted for opposition 31
on 08th May 2018		Formalized
Submitted for opposition 30
on 04th May 2018		Filed
Submitted for opposition 1
on 04th May 2018		Created